Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
6 papers
Recent·Most cited
M. A. O'Connor, D. W. Hawman, K. Meade-White…·J. H. Erasmus
This study shows a replicon RNA vaccine provides durable protection against SARS-CoV-2 in nonhuman primates even after neutralizing antibodies decline.
A. C. Walls, L. A. VanBlargan, K. Wu…·D. Veesler
This study compares neutralizing antibody responses to SARS-CoV-2 variants in vaccinated humans and mice, finding that mice do not accurately reflect the breadth and potency seen in humans.
A. C. Walls, M. C. Miranda, M. N. Pham…·Veesler
This study shows that a SARS-CoV-2 RBD nanoparticle vaccine protects against SARS-CoV-2 and related sarbecoviruses, including variants, in mice and non-human primates.
H. C. Tunggal, P. V. Munson, M. A. O'Connor…·D. H. Fuller
This study shows that a therapeutic DNA vaccine with adjuvants protects some SIV-infected macaques from viral rebound by enhancing polyfunctional CD8 T cells in blood and gut lymph nodes.
A. C. Walls, B. Fiala, A. Schaefer…·N. P. King
This study designs SARS-CoV-2 nanoparticle vaccines that induce strong neutralizing antibodies in mice, with higher titers and lower doses than existing trimer vaccines.